For the Patient

Expected Benefits to the Patient

VPS is designed to enable placement of the catheter correctly the first time
Since the VPS uses the patient's physiological characteristics to determine the catheter's location, clinicians know when the catheter is placed at the lower third of the SVC. This may reduce the need for adjustments and subsequent X-ray exposure, potentially reducing the patient's exposure to X-rays and related adverse outcomes from X-rays.
Improved likelihood of continuity of care
Use of the VPS may minimize disruption of care for the patient and increases timeliness of medication administration.
No external device on chest to induce potential discomfort
Without the nuisance of an external device placed on the patient's chest, the VasoNova VPS allows the patient to remain comfortable and breathe normally during the procedure.
Optimal placement improves infusion efficiency
Precise placement with the VasoNova VPS at the lower third of SVC, specifically at the CAJ, allows the turbulent blood flow at CAJ to quickly mix and dilute infused fluids, such as drugs, by the patient's blood, ensuring rapid transportation to the rest of the body.
Effective in many* patients, including those with obesity or challenges with body habitus
Unlike other catheter placement technologies, the VasoNova VPS is not limited by the size of the patient.
Latex-free components to maximize comfort and safety
Increase safety for patients who are allergic to latex.
Potential Complications:
Before attempting catheter placement, ensure that you are familiar with all possible complications and their emergency treatment should any of them occur. Complications are: air embolism, bleeding, brachial plexus injury, cardiac arrhythmia, cardiac tamponade, catheter erosion through skin, catheter embolism, catheter occlusion, catheter related sepsis, endocarditis, exit site infection, exit site necrosis, extravasation, fibrin sheath formation, hematoma, intolerance reaction to implanted device, laceration of vessels or viscus, myocardial erosion, perforation of vessels or viscus phlebitis, pneumothorax, spontaneous catheter tip malposition or retraction, venous thrombosis, ventricular thrombosis, vessel erosion, risks normally associated with local or general anesthesia, surgery, and postoperative recovery. Use of this product should be in accordance with the instructions provided and as directed by the prescribing physician. See package IFU and website for additional information.